Major Depression Disorder Clinical Trial
Official title:
Interventional, Open-label, Flexible-dose, Long-term Study to Evaluate the Safety and Tolerability of Brexpiprazole as Adjunctive Treatment in Elderly Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
The purpose of this study is to evaluate the safety and tolerability of brexpiprazole as adjunctive treatment in an elderly population with major depressive disorder and an inadequate response to antidepressant treatment
n/a
Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02773108 -
Somatic Comorbidities in Psychiatric Patients
|
||
Recruiting |
NCT05597566 -
Predictive Effect of Neuroinflammatory Factors of the MECT in Treatment of Senile Depression
|
||
Recruiting |
NCT06278038 -
Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-release Tablets Versus Venlafaxine Hydrochloride Sustained-release Tablets in Patients With Major Depression Disorder
|
N/A | |
Recruiting |
NCT02273154 -
Randomized,Controlled and Open-label Study of Buspirone add-on Treatment in Patients With Major Depression Disorder
|
Phase 4 |